GAC Motor, China’s leading automaker, released a new brand image and corporate culture for the company’s decennial celebration. The new vision, which aims to highlight the aspirations of one of China’s leading auto brands as it begins to embark on its next stage of development.
“Achieving great progress in business not only depends on high-quality products and brand strength but also in the guidance of corporate culture,” said Yu Jun, President of GAC Motor. “Therefore, GAC Motor upon celebrating its 10th anniversary has decided to update our image with a new brand slogan and a renewed effort to upgrade our corporate culture. Aiming to further, empower, motivate and inspire our workforce to ensure our continued long-term development into the next decade.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8379451-gac-motor-10-year-anniversary-road-to-greatness-campaign/
Messe Frankfurt looks back on a 45-year-long tradition of success in the automotive industry and takes this opportunity to thank its long-term and loyal exhibitors. It has come up with something special for this occasion: the artist and photographer Rafael Neff has converted several customer products into theme worlds that are featured in the 2016 Automechanika calendar: Alfred Kärcher GmbH & Co. KG, BBS GmbH, Brembo S.p.A., Continental Aftermarket GmbH,Continental Reifen Deutschland GmbH,Hella KGaA Hueck & Co, Johnson Controls Autobatterie GmbH & Co. KGaA, Liqui Moly GmbH, Mahle GmbH, MANN+HUMMEL GmbH, RECARO Automotive Ltd. & Co. KG, Schaeffler AG, ZF Friedrichshafen AG. The high-quality calendar was presented at the ‘We say THANKS’ ceremony in the Klassikstadt Frankfurt, to which Messe Frankfurt issued an invitation.
Automechanika is certainly the most exciting success story in 45 years. The story began in 1971 with the first Automechanika in Frankfurt, which was christened when the IAA was cancelled. In subsequent years, the trade fair has made outstanding progress, advancing to the world’s leading trade fair, which is now held in fifteen locations worldwide. In the meantime, Messe Frankfurt is also organising a series of new B2B trade fairs for trucking and logistics and B2C events for automobiles, bikes, and boats.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7668651-messe-frankfurt-expands-logistics-sectors/
According to a new survey from the American Institute of Certified Public Accountants (AICPA) and the Ad Council, one in three millennials (34 percent) ranked saving as their number one goal for the year – ahead of living a healthy lifestyle (20 percent), paying off debt (19 percent), and losing weight (14 percent). But while saving was a top priority, a majority of millennials attributed their lack of saving to impulse buying (65 percent).
For older millennials, those born between the early 1980’s and early 1990’s, saving is crucial as they work towards major milestones in their lives. When asked what they were saving money towards, respondents sought to secure their future by saving for an emergency fund (40 percent), saving for retirement (22 percent) or starting a family (15 percent). They also reported saving for larger purchases like a vacation (36 percent), a new house (27 percent), a car (26 percent), home improvements (20 percent), or a wedding (8 percent). To provide Americans aged 25 to 34 with the tips and tools to take control of their personal finances, AICPA and the Ad Council’s national advertising campaign, Feed the Pig, is continuing to collaborate with new partners to deliver this critical content in a relevant and engaging way.
“Many young adults think saving is impossible,” said Gregory Anton, CPA, CGMA, chair of the AICPA’s National CPA Financial Literacy Commission. “While low salaries and high debt levels can certainly be barriers to saving, the key is to create a budget and stick to it. Establishing a disciplined saving strategy early in life and avoiding missteps will reap substantial long-term dividends.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7790851-ad-council-feed-the-pig/
A recently published scientific study from Lund University by lead researcher Charlotte Erlanson-Albertsson, MD, PhD found that subjects who were trying to lose weight and used the patented spinach extract Appethyl on a daily basis lost 43 percent more weight compared to those ingesting a placebo.
In this clinical trial, overweight women were given either a daily five gram dose of Appethyl or a control drink immediately before breakfast. Researchers found that the weight of the women ingesting Appethyl decreased significantly at 43 percent more than subjects ingesting the control drink.
This is one of three studies that also compared the effects of Appethyl after 90 days with those found after the first dose and found no decline of effects, indicating that Appethyl takes effect after the first dose and is just as effective after long-term use. One study showed that Appethyl reduced hunger by 25 percent four hours after consumption, in addition to reducing thoughts about food by 33 percent.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7426951-appethyl-spinach-extract/
Lustgarten Foundation funded researchers at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins have designed a multi-analyte blood test that can detect the presence of pancreatic cancer as part of a panel of eight common cancers (pancreas, ovary, liver, stomach, esophagus, colorectum, lung and breast) as reported in the online edition of Science today. The test utilizes combined assays for genetic alterations and protein biomarkers and has the capacity not only to identify the presence of relatively early cancer, but also to localize the organ of origin of these cancers.
“The potential this has for pancreatic cancer is unprecedented,” says Anne Marie Lennon, M.D., Ph.D., Associate Professor of Medicine, Director, Pancreatic Cyst Center of the Ludwig Center at the Johns Hopkins Kimmel Cancer Center. “We know that in 80-85 percent of pancreatic cancer cases, it’s detected too late, leaving the patient with few options. Developing a blood screening test for pancreatic cancer has been an urgent goal, because catching the disease early will be the way we get to long-term survival.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213751-lustgarten-foundation-pancreatic-cancer-blood-test/
Entry-level employees are becoming less proficient in the skills most needed to succeed in today’s workplace, according to a recent national survey of human resources (HR) managers responsible for hiring. The survey, sponsored by leading early education provider Primrose Schools®, revealed skills like adaptability, teamwork and problem solving are critical to workplace success. Yet, 70 percent of seasoned HR managers report that entry-level employees are rarely proficient in these skills.
According to the survey, critical thinking, problem solving, teamwork, self-control, adaptability and working memory – collectively referred to by educators as executive function skills – are more highly valued in entry-level candidates than technical abilities, academic background and other factors. And while respondents state that entry-level employees are rarely proficient in these skills, two-thirds say hiring entry-level employees with good executive function skills is a top priority for their company’s long-term success.
To view the multimedia release go to:
https://www.multivu.com/players/English/8014453-primrose-schools-early-childhood-career-success-survey/
Let’s Win, an initiative supported by the Lustgarten Foundation, launched the Let’s Win! Pancreatic Cancer Survivors video series Friday, January 19, 2018, at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium. The new online video series, featuring long-term pancreatic cancer survivors of all ages and diverse backgrounds, has been created to show pancreatic cancer patients and their families that people do survive this disease. The survivors have responded exceptionally well to pancreatic cancer therapy that incorporates clinical trials and treatments that go beyond traditional protocols.
When patients are first diagnosed with pancreatic cancer, they often turn to the internet, only to find devastating and frightening statistics about the disease. “Our goal is to provide hope and inspiration to patients and their families,” says Cindy Gavin, founding executive director of Let’s Win. “We are so grateful for the incredible vision of one special patient and the generosity of The Flora Family Foundation for their support of this incredible initiative.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8213752-lets-win-pancreatic-cancer-survivor-video-series/
The G-Global info-communicative platform hosted an online conference on the 19th March on the theme “Draft Plan for overcoming long-term consequences of the global financial and economic crisis for UN Member States” in preparation for the second World Anti-Crisis Conference to be held in the Kazakhstan capital, Astana, on 21-23 May 2014. Mark Uzan, director of the Renovating Bretton Woods Committee, moderated the online-conference in which international and Kazakhstan experts participated. They reached agreement on a consolidated draft Plan for overcoming long-term consequences of the global financial and economic crisis for UN Member States (Plan) on which the international expert community has been actively working.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7140055-g-global-info-communicative-platform-draft-plan
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease.
With this FDA approval, Boston Scientific will commence commercialization of the first and only BP-DES in the U.S. Notably, both the drug coating and the polymer – which modulates drug release – are fully absorbed shortly after drug elution is complete at three months.
The SYNERGY Stent provides synchronized drug and polymer absorption. It is designed to enable more rapid and complete arterial healing, and to thereby reduce the risk of complications associated with long-term polymer exposure compared to currently-used drug-eluting stents (DES) with permanent polymers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7223456-boston-scientific-fda-approval-synergy/
Imagine finding the most qualified candidate for a job, but that person is blind. Or perhaps a long-term employee experiences vision loss as a result of an accident. What would an employer need to do to accommodate that person? Is the employee able to keep the job?
Serving as a national model for how technology can create job opportunities and accessible workplaces for people without vision, Indianapolis-based nonprofit Bosma Enterprises is one of the first organizations in the U.S. to use BlindSquare, an innovative wayfinding technology. Bosma is using BlindSquare to help clients and employees better navigate its new, state-of-the-art headquarters, which opened June 2, and is representative of the nonprofit’s mission to assist people who are blind or visually impaired gain the life skills they need to remain independent, and the job skills they need to stay self-sufficient.
To view the multimedia release go to:
https://www.multivu.com/players/English/8116051-bosma-enterprises-blindsquare-mobile-navigation-technology/
Losing weight and being healthier are at the top of everyone’s New Year’s resolutions. But, despite the best intentions, work, kids, and social events often push lifestyle changes to the bottom of the list. While many are familiar with type 2 diabetes, fewer are aware of prediabetes, a serious health condition that affects 86 million Americans (more than 1 in 3) and often leads to type 2 diabetes. People with prediabetes have higher than normal blood glucose (sugar) levels, but not high enough yet to be diagnosed with type 2 diabetes.
To raise awareness and help people with prediabetes know where they stand and how to prevent type 2 diabetes, the American Diabetes Association (ADA), the American Medical Association (AMA), and the Centers for Disease Control and Prevention (CDC) have partnered with the Ad Council to launch the first national public service advertising (PSA) campaign about prediabetes. The PSA campaign, featuring first-of-its-kind communications techniques, was developed pro bono by Ogilvy & Mather New York for the Ad Council.
Nearly 90 percent of people with prediabetes don’t know they have it and aren’t aware of the long-term risks to their health, including type 2 diabetes, heart attack, and stroke. Current trends suggest that, if not treated, 15 to 30 percent of people with prediabetes will develop type 2 diabetes within five years. The good news is that prediabetes often can be reversed through weight loss, diet changes and increased physical activity. Diagnosis is key: research shows that once people are aware of their condition, they are much more likely to make the necessary lifestyle changes.
To view the multimedia release go to:
http://www.multivu.com/players/English/7731551-ad-council-prediabetes-psa/
The first comprehensive long-term study comparing different medications for type 2 diabetes is launching nationwide. The GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Study will compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64578-grade-glycemia-reduction-approaches-in-diabetes-comparative-effectiveness
